🐜
|
The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes.
22 auth.
A. Kostic,
D. Gevers,
Heli Siljander,
T. Vatanen,
T. Hyötyläinen,
A. Hämäläinen,
A. Peet,
V. Tillmann,
Päivi Pöhö,
I. Mattila,
...
H. Lähdesmäki,
E. Franzosa,
O. Vaarala,
M. D. de Goffau,
H. Harmsen,
J. Ilonen,
S. Virtanen,
C. Clish,
M. Orešič,
C. Huttenhower,
M. Knip,
R. Xavier
|
9 |
2015 |
9 🐜
|
🐜
|
Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans
25 auth.
T. Vatanen,
A. Kostic,
Eva d’Hennezel,
Heli Siljander,
E. Franzosa,
M. Yassour,
R. Kolde,
H. Vlamakis,
Timothy D. Arthur,
A. Hämäläinen,
A. Peet,
V. Tillmann,
R. Uibo,
Sergei Mokurov,
N. Dorshakova,
...
J. Ilonen,
S. Virtanen,
S. Szabo,
Jeffrey A. Porter,
H. Lähdesmäki,
C. Huttenhower,
D. Gevers,
T. W. Cullen,
M. Knip,
R. Xavier
|
9 |
2016 |
9 🐜
|
🐜
|
The human gut microbiome in early-onset type 1 diabetes from the TEDDY study
22 auth.
T. Vatanen,
E. Franzosa,
Randall Schwager,
Surya Tripathi,
Timothy D. Arthur,
Kendra Vehik,
Å. Lernmark,
W. Hagopian,
M. Rewers,
J. She,
...
J. Toppari,
A. Ziegler,
B. Akolkar,
J. Krischer,
C. Stewart,
N. Ajami,
J. Petrosino,
D. Gevers,
H. Lähdesmäki,
H. Vlamakis,
C. Huttenhower,
R. Xavier
|
9 |
2018 |
9 🐜
|
🐜
|
The transcription factor NFAT promotes exhaustion of activated CD8⁺ T cells.
18 auth.
G. Martinez,
R. M. Pereira,
Tarmo Äijö,
Tarmo Äijö,
Edward Y. Kim,
F. Marangoni,
M. Pipkin,
M. Pipkin,
Susan M. Togher,
V. Heissmeyer,
...
Yi Chen Zhang,
S. Crotty,
E. Lamperti,
K. M. Ansel,
T. Mempel,
H. Lähdesmäki,
P. Hogan,
A. Rao
|
9 |
2015 |
9 🐜
|
🐜
|
Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX
13 auth.
M. Ko,
Jungeun An,
Hozefa S. Bandukwala,
L. Chavez,
Tarmo Äijö,
William A. Pastor,
M. Segal,
Huiming Li,
Kian Peng Koh,
H. Lähdesmäki,
...
P. Hogan,
L. Aravind,
A. Rao
|
8 |
2013 |
8 🐜
|
🦁
|
On Learning Gene Regulatory Networks Under the Boolean Network Model
H. Lähdesmäki,
I. Shmulevich,
O. Yli-Harja
|
8 |
2003 |
8 🦁
|
🐜
|
Control of Foxp3 stability through modulation of TET activity
12 auth.
Xiaojing Yue,
S. Trifari,
Tarmo Äijö,
Ageliki Tsagaratou,
William A. Pastor,
J. A. Zepeda-Martínez,
...
C. Lio,
Xiang Li,
Yun Huang,
P. Vijayanand,
H. Lähdesmäki,
A. Rao
|
8 |
2016 |
8 🐜
|
🐜
|
Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer
10 auth.
Sanni E. Jalava,
A. Urbanucci,
Leena Latonen,
Kati K. Waltering,
Biswajyoti Sahu,
O. Jänne,
...
Janne Seppälä,
H. Lähdesmäki,
T. Tammela,
T. Visakorpi
|
7 |
2012 |
7 🐜
|
🐜
|
Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis
14 auth.
X. Hao,
Baocun Sun,
Limei Hu,
H. Lähdesmäki,
V. Dunmire,
Yu-mei Feng,
Shiwu Zhang,
Huamin Wang,
Chunlei Wu,
Hua Wang,
...
G. Fuller,
W. Symmans,
I. Shmulevich,
Wei Zhang
|
7 |
2004 |
7 🐜
|
🐜
|
Genomic variation and strain-specific functional adaptation in the human gut microbiome during early life
28 auth.
T. Vatanen,
D. Plichta,
J. Somani,
Philipp C. Münch,
Timothy D. Arthur,
A. B. Hall,
Sabine Rudolf,
E. Oakeley,
Xiaobo Ke,
R. A. Young,
Henry J. Haiser,
R. Kolde,
M. Yassour,
Kristiina Luopajärvi,
Heli Siljander,
...
S. Virtanen,
J. Ilonen,
R. Uibo,
V. Tillmann,
Sergei Mokurov,
N. Dorshakova,
Jeffrey A. Porter,
A. Mchardy,
H. Lähdesmäki,
H. Vlamakis,
C. Huttenhower,
M. Knip,
R. Xavier
|
7 |
2018 |
7 🐜
|
🐜
|
Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1–BAP1 complex
8 auth.
A. Balasubramani,
Antti Larjo,
J. Bassein,
Xing Chang,
Ryan B. Hastie,
Susan M. Togher,
...
H. Lähdesmäki,
A. Rao
|
7 |
2015 |
7 🐜
|
🐜
|
Innate Immune Activity Is Detected Prior to Seroconversion in Children With HLA-Conferred Type 1 Diabetes Susceptibility
16 auth.
Henna Kallionpää,
L. Elo,
Essi Laajala,
J. Mykkänen,
I. Ricaño-Ponce,
Matti Vaarma,
T. Laajala,
H. Hyöty,
J. Ilonen,
R. Veijola,
...
T. Simell,
C. Wijmenga,
M. Knip,
H. Lähdesmäki,
O. Simell,
R. Lahesmaa
|
7 |
2014 |
7 🐜
|